Kidney & Blood Pressure Research · 2019 · 22 citations · 36 references
MedicineNephrologyNutritionCalcium HomeostasisClinical NutritionDialysisChronic Kidney DiseaseRenal DiseaseRenal ImpairmentRenal NutritionAlkali TreatmentCohort Study InvestigationPlasma Bicarbonate ConcentrationRenal Vascular CalcificationSodium Bicarbonate SupplementationSodium Bicarbonate TherapySodium SupplementationVascular Calcification Assessment
<b><i>Background:</i></b> Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) and metabolic acidosis might accelerate vascular calcification. The T<sub>50</sub> calcification inhibition test (T<sub>50</sub>-test) is a global functional test analyzing the overall propensity of calcification in serum, and low T<sub>50</sub>-time is associated with progressive aortic stiffening and with all-cause mortality in non-dialysis CKD, dialysis, and transplant patients. Low serum bicarbonate is associated with a short T<sub>50</sub>-time and alkali supplementation could be a simple modifier of calcification propensity. The aim of this study was to investigate the short-term effect of oral sodium bicarbonate supplementation on T<sub>50</sub>-time in CKD patients. <b><i>Material and Methods:</i></b> The SoBic-study is an ongoing randomized-controlled trial in CKD-G3 and G4 patients with chronic metabolic acidosis (serum HCO<sub>3</sub><sup>–</sup> ≤21 mmol/L), in which patients are randomized to either achieve serum HCO<sub>3</sub><sup>–</sup> levels of 24 ± 1 mmol/L (intervention group) or 20 ± 1 mmol/L (rescue group). The effect of bicarbonate treatment on T<sub>50</sub>-time was assessed. <b><i>Results:</i></b> The study cohort consisted of 35 (14 female) patients aged 57 (±15) years, and 18 were randomized to the intervention group. The mean T<sub>50</sub>-time was 275 (± 64) min. After 4 weeks, the mean change of T<sub>50</sub>-time was 4 (±69) min in the intervention group and 18 min (±56) in the rescue group (β = –25; 95% CI: –71 to 22; <i>p</i> = 0.298). Moreover, change of serum bicarbonate in individual patients was not associated with change in T<sub>50</sub>-time, analyzed by regression analysis. Change of serum phosphate had a significant impact on change of T<sub>50</sub>-time (β = –145; 95% CI: –237 to –52). <b><i>Conclusion:</i></b> Oral sodium bicarbonate supplementation showed no effect on T<sub>50</sub>-time in acidotic CKD patients.
36
Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease
Jacques Blacher, Alain P. Guérin, Bruno Pannier et al. · Hypertension · 2001 · 1.4K citations
Medicine, Cardiology, Nephrology +13
Wheeler Dc, WC Winkelmayer · UCL Discovery (University College London) · 2017 · 485 citations
Medicine, Nephrology, Pediatrics +17